Radioiodine treatment of well-differentiated thyroid cancer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Antitumor Effect ofNanoscale research letters · 2019
   Article
2. Association of the Cumulative Dose of Radioactive Iodine Therapy With Overall Survival in Patients With Differentiated Thyroid Cancer and Pulmonary Metastases.Frontiers in oncology · 2019
   Article
3. Hyperplastic thymus with increased angiogenesis is correlated with elevated serum thyroglobulin level in differentiated thyroid cancer patients with TENIS syndrome.Oncotarget · 2018
   Article
4. The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER.OncoTargets and therapy · 2018
   Article
5. Low versus high radioiodine activity for ablation of the thyroid remnant after thyroidectomy in Han Chinese with low-risk differentiated thyroid cancer.OncoTargets and therapy · 2017
   Article
6. Correlation of Consecutive Serum Thyroglobulin Levels During Hormone Withdrawal and Failure of Initial Radioiodine Ablation in Thyroid Cancer Patients.Nuclear medicine and molecular imaging · 2015
   Article
7. Diagnosis and treatment of patients with thyroid cancer.American health & drug benefits · 2015
   Review
8. Can increased tumoral vascularity be a quantitative predicting factor of lymph node metastasis in papillary thyroid microcarcinoma?Endocrine · 2014
   Article
9. Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.BMC cancer · 2014
   Review
10. Radioiodide induces apoptosis in human thyroid tissue in culture.Endocrine · 2013
    Article
11. Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases.Endocrine · 2013
    Article
12. Prophylactic central lymph node dissection in differentiated thyroid cancer.Endocrine · 2013
    Article
13. Should patients with remnants from thyroid microcarcinoma really not be treated with iodine-131 ablation?Endocrine · 2013
    Article
14. Total thyroidectomy and central lymph node dissection. Experience of a referral centre for endocrine surgery.Il Giornale di chirurgia
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as